Melanoma Trial, Recruiting NCT04778449 Sponsor: M.D. Anderson Cancer Center Condition: Melanoma
Back to Melanoma

Melanoma Trial, Recruiting

NCT04778449
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with melanoma, a related skin condition, or a precursor skin lesion (an early skin change that could develop into melanoma)
  • You are able to read and understand English
  • You are willing to fill out a survey, either online or on paper

Who may not be able to join:

  • There are no specific exclusion criteria listed for this trial (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Carrie Daniel-MacDougall, M.D. Anderson Cancer Center

Phone: 713-563-5783

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
26 August 2015
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in depression/distress; Change in anxiety; Change in cancer-related symptoms; Change in social support; Change in general eating habits; Change in physical activity; Associations between mental health, social support, diet and exercise behaviors, and quality of life and demographic variables; Effect of diet, physical activity, depressive symptoms, distress, lifetime MDD, and social support on progression free survival; Effect of diet, physical activity, depressive symptoms, distress, lifetime MDD, and social support on cancer mortality; Response to treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov